cadralazine has been researched along with Lupus Erythematosus, Systemic in 3 studies
cadralazine: structure given in first source
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mulder, H | 1 |
| Pålsson, L | 1 |
| Weiner, L | 1 |
| Englund, G | 1 |
| Henning, M | 1 |
| Andersson, OK | 1 |
3 other studies available for cadralazine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Conversion of drug-induced SLE-syndrome by the vasodilating agent cadralazine.
Topics: Adult; Blood Pressure; Humans; Hydralazine; Hypertension; Lupus Erythematosus, Systemic; Male; Pyrid | 1990 |
Cadralazine challenge in patients with previous hydralazine-induced lupus: a 6-month study.
Topics: Acetylation; Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Lupu | 1989 |
Cadralazine did not produce the SLE-syndrome when hydralazine did.
Topics: Adult; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Pyridazines | 1987 |